Medicines agency introduces greater transparencyBMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7428.1368-d (Published 11 December 2003) Cite this as: BMJ 2003;327:1368
- Liza Gibson
The Medicines and Healthcare Products Regulatory Agency (MHRA), which was officially launched last week, has initiated several moves to improve its transparency and public profile.
The agency has decided to publish the outcome of its investigations into complaints about pharmaceutical company advertising.
It will publish on its website the outcome of complaints received from 1 December. Details will include a description …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial